Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Botana Rial, P. Casado Rey, M. A. Andrade Olivié, A. Fernández-Villar, V. Leiro Fernández, C. Represas Represas, A. Pallarés Sanmartín, A. Cobas Paz (Vigo, Spain). Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion. Eur Respir J 2009; 34: Suppl. 53, 1925

Member's Comments

No comment yet.

Related content which might interest you: C-reactive protein in differentiation between tuberculous and malignant pleural effusions Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Diagnostic value of C-reactive protein in exudative pleural effusions Source: International Congress 2019 – Clinical problems Year: 2019 The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 The implication of C-reactive protein in differentiation of various pleural effusion etiologies Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Procalcitonin and CRP levels in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Usefulness of procalcitonin as a diagnostic marker of pleural effusion Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009 Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003 Diagnostic value of NT-proBNP levels in differentiation of cardiac origin of pleural effusions Source: Annual Congress 2008 - Pleural effusion Year: 2008 Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020 Diagnostic value of amylase levels in pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 Role of C-reactive protein in distinguishing between transudative and exudative pleural effusion Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Diagnostic and prognostic significance of survivin levels in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 The diagnostic value of CA-125 in pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001